marijuana stocks

Tilray to Report First Quarter 2020 Financial Results on May 11, 2020

Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for the first quarter ended March 31, 2020 on Monday, May 11, 2020 after market close.

The Company will host a conference call to discuss these results at 5:00 p.m. ET. Investors interested in participating in the live call can dial 877-489-6528 from the U.S. and 629-228-0736 internationally. A telephone replay will be available approximately two hours after the call concludes through Tuesday, May 26, 2020, by dialing 855-859-2056 from the U.S., or 404-537-3406 from international locations, and entering confirmation code 7890876.

There will also be a simultaneous, live webcast available on the Investors section of the Company’s website at www.tilray.com. The webcast will be archived for 30 days.

About Tilray®

Tilray (Nasdaq: TLRY) is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in 15 countries spanning five continents.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200504005193/en/

Contacts

For further information:
Media: Chrissy Roebuck, +1-833-206-8161, news@tilray.com
Investors: Raphael Gross, +1-203-682-8253, Raphael.Gross@icrinc.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Koios Beverage Corp. (KBEV) (KBEVF) adds Keef Brands President and COO Travis Tharp to its Advisory Board

Koios adds Keef Brands President and COO Travis Tharp to its Advisory…

TILT Holdings Inc. (TLLTF) Enters into Exclusive Manufacture and Distribution Agreement with Curaleaf International

TILT Holdings Enters into Exclusive Manufacture and Distribution Agreement with Curaleaf International…

AbbVie Inc. (ABBV) Cariprazine (VRAYLAR®) Met Primary Endpoint in Phase 3 Study

AbbVie’s Cariprazine (VRAYLAR®) Met Primary Endpoint in Phase 3 Study as an…

Cresco Labs Inc. (CRLBF) Announces Opening of Sunnyside Philadelphia, Its Fourth Dispensary in Pennsylvania

Cresco Labs Announces Opening of Sunnyside Philadelphia, Its Fourth Dispensary in Pennsylvania…